Published 09-09-16
Issued by Amgen
Amgen has launched its 2015 Environmental Sustainability Report highlighting the Company’s environmental sustainability progress. The 2015 Environmental Sustainability Report documents performance of a key aspect of Amgen’s broad commitments to environmental and social responsibility, as detailed in the Responsibility section of Amgen’s website and featured in this video.
Amgen has launched its 2015 Environmental Sustainability Report highlighting the Company’s environmental sustainability progress. The 2015 Environmental Sustainability Report documents performance of a key aspect of Amgen’s broad commitments to environmental and social responsibility, as detailed in the Responsibility section of Amgen’s website and featured in this video.
Amgen has a commitment to making a positive impact in the world that goes beyond its medicines to include all aspects of the company’s operations and actions. As evidence of the Company’s broader positive impact, Corporate Responsibility Magazine listed Amgen as one of the 100 Best Corporate Citizens. In addition, in 2015, Amgen earned placement in the Dow Jones Sustainability World Index for a second year and was named to the North America Index for a third year.
Included in Amgen’s 2015 Environmental Sustainability Report:
About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.
x